Routine Health Screening Market
Report Scope
The routine health screening market presents a vast and promising opportunity as it responds to evolving healthcare trends and societal needs. With an increasing emphasis on preventive healthcare, routine health screenings have become instrumental in detecting potential health issues at early stages. The market’s expansion is propelled by the rising incidence of non-communicable diseases, such as diabetes and cardiovascular disorders, coupled with the aging global population, necessitating proactive health management strategies. Technological advancements, including innovations in diagnostic tools and the integration of artificial intelligence, enhance the accuracy and accessibility of screenings, catering to a broader demographic. The aftermath of the COVID-19 pandemic has further underscored the importance of regular health check-ups, reinforcing the significance of routine health screenings.
Additionally, incorporating these screenings into corporate wellness programs and the trend toward personalized medicine further amplifies the market’s potential. The routine health screening market is poised for substantial expansion, playing a pivotal role in the proactive and personalized management of individual health globally. This report presents insights into this market’s current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges, and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies, and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes
The routine health screening market presents a vast and promising opportunity as it responds to evolving healthcare trends and societal needs. With an increasing emphasis on preventive healthcare, routine health screenings have become instrumental in detecting potential health issues at early stages. The market’s expansion is propelled by the rising incidence of non-communicable diseases, such as diabetes and cardiovascular disorders, coupled with the aging global population, necessitating proactive health management strategies. Technological advancements, including innovations in diagnostic tools and the integration of artificial intelligence, enhance the accuracy and accessibility of screenings, catering to a broader demographic. The aftermath of the COVID-19 pandemic has further underscored the importance of regular health check-ups, reinforcing the significance of routine health screenings.
Additionally, incorporating these screenings into corporate wellness programs and the trend toward personalized medicine further amplifies the market’s potential. The routine health screening market is poised for substantial expansion, playing a pivotal role in the proactive and personalized management of individual health globally. This report presents insights into this market’s current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges, and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies, and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes
- 37 data tables and 39 additional tables
- An overview of the global market for routine health screening
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by test type, sample type, technology, and region
- A look at recent innovations, technological advances, and product launches in the market
- Analysis of the industry’s regulatory framework and policies
- A discussion of ESG challenges and practices in the routine health screening industry
- An analysis of the key companies’ market shares, proprietary technologies, alliances, and other strategies
- A discussion of key patents
- Profiles of the leading players, including Quest Diagnostics, Laboratory Corporation of America Holdings, Sonic Healthcare Ltd., Eurofins Scientific, and SYNLAB AG
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Cholesterol Test
Diabetes Test
Blood Pressure Test
Cancer Screening Test
Prenatal Testing
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Check
Others
CHAPTER 3 MARKET DYNAMICS
Factors Affecting the Routine Health Screening Market
Market Drivers
Advancements in Screening Technologies
Growing Prevalence of Chronic Diseases
Growing Health Consciousness
Increasing Healthcare Spending
Market Restraints
High Costs Associated with Routine Health Screening
Psychological Barriers
Lack of Awareness and Acceptability in Low and Middle Income Countries
Market Challenges
False Positive and False Negative Screening Test Results
Declining Reimbursement
Market Opportunities
Adoption of AI in Routine Health Screening
Expansive Opportunities in Emerging Economies
CHAPTER 4 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Routine Health Screening Market, by Test Type
Cholesterol Screening
Diabetes Screening
Blood Pressure Test
Cancer Screening
Prenatal Screening
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Tests
Others
Routine Health Screening Market, by Sample Type
Overview
Blood-Based Sample
Urine-Based Sample
Imaging Sample
Other Samples
Routine Health Screening Market, by Technology
Overview
QPCR (Quantitative Polymerase Chain Reaction)
Q-FISH (Quantitative Fluorescence In Situ Hybridization) Technology
Immunoassays
Medical Imaging
STELA (Single Telomere Length Analysis)
Other Technologies
Geographic Breakdown
Routine Health Screening Market, by Region
North America
Asia-Pacific
Europe
Rest of the World
CHAPTER 5 EMERGING AND UPCOMING TECHNOLOGIES IN THE MARKET
Introduction
Emerging and Upcoming Technologies
Deep Phenotyping Technologies
Digital Health Interventions
Digital Precision Medicine
Wearable Devices and Remote Monitoring
Multicancer Detection (MCDs) Assays
Artificial Intelligence in Routine Health Screening
5G-ENABLED DEVICES
Genetics Testing
Technological Concerns in the Routine Health Screening Market
Efficacy Data
Data Privacy
Regulatory Landscape
Supply Chain Challenges
Recent Developments
CHAPTER 6 ESG DEVELOPMENT
Introduction
Sustainability in Routine Health Screening Industry
WHO Global Action Plan
BCC Research Viewpoint
CHAPTER 7 COMPETITIVE LANDSCAPE
Mergers, Acquisitions and Collaborations
Manufacturer and Service Provider Market Share Analysis
Strategic Alliances
CHAPTER 8 APPENDIX
Methodology
Sources
Abbreviations
Company Profiles
ARUP LABORATORIES
CERBA HEALTHCARE
EUROFINS SCIENTIFIC
EXACT SCIENCE CORP.
OPKO HEALTH INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
NATERA INC.
QUEST DIAGNOSTICS INC.
SONIC HEALTHCARE LTD.
SYNLAB AG
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Cholesterol Test
Diabetes Test
Blood Pressure Test
Cancer Screening Test
Prenatal Testing
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Check
Others
CHAPTER 3 MARKET DYNAMICS
Factors Affecting the Routine Health Screening Market
Market Drivers
Advancements in Screening Technologies
Growing Prevalence of Chronic Diseases
Growing Health Consciousness
Increasing Healthcare Spending
Market Restraints
High Costs Associated with Routine Health Screening
Psychological Barriers
Lack of Awareness and Acceptability in Low and Middle Income Countries
Market Challenges
False Positive and False Negative Screening Test Results
Declining Reimbursement
Market Opportunities
Adoption of AI in Routine Health Screening
Expansive Opportunities in Emerging Economies
CHAPTER 4 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Routine Health Screening Market, by Test Type
Cholesterol Screening
Diabetes Screening
Blood Pressure Test
Cancer Screening
Prenatal Screening
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Tests
Others
Routine Health Screening Market, by Sample Type
Overview
Blood-Based Sample
Urine-Based Sample
Imaging Sample
Other Samples
Routine Health Screening Market, by Technology
Overview
QPCR (Quantitative Polymerase Chain Reaction)
Q-FISH (Quantitative Fluorescence In Situ Hybridization) Technology
Immunoassays
Medical Imaging
STELA (Single Telomere Length Analysis)
Other Technologies
Geographic Breakdown
Routine Health Screening Market, by Region
North America
Asia-Pacific
Europe
Rest of the World
CHAPTER 5 EMERGING AND UPCOMING TECHNOLOGIES IN THE MARKET
Introduction
Emerging and Upcoming Technologies
Deep Phenotyping Technologies
Digital Health Interventions
Digital Precision Medicine
Wearable Devices and Remote Monitoring
Multicancer Detection (MCDs) Assays
Artificial Intelligence in Routine Health Screening
5G-ENABLED DEVICES
Genetics Testing
Technological Concerns in the Routine Health Screening Market
Efficacy Data
Data Privacy
Regulatory Landscape
Supply Chain Challenges
Recent Developments
CHAPTER 6 ESG DEVELOPMENT
Introduction
Sustainability in Routine Health Screening Industry
WHO Global Action Plan
BCC Research Viewpoint
CHAPTER 7 COMPETITIVE LANDSCAPE
Mergers, Acquisitions and Collaborations
Manufacturer and Service Provider Market Share Analysis
Strategic Alliances
CHAPTER 8 APPENDIX
Methodology
Sources
Abbreviations
Company Profiles
ARUP LABORATORIES
CERBA HEALTHCARE
EUROFINS SCIENTIFIC
EXACT SCIENCE CORP.
OPKO HEALTH INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
NATERA INC.
QUEST DIAGNOSTICS INC.
SONIC HEALTHCARE LTD.
SYNLAB AG
LIST OF TABLES
Summary Table : Global Routine Health Screening Market, by Test Type, Through 2029
Table 1 : Projected Number of Adults 50 Years and Older with More than One Chronic Condition in the United States, 2020-2050
Table 2 : Estimated False Positive Probability of One Screening Occasion
Table 3 : Preventive Health Screenings, by Age
Table 4 : Global Routine Health Screening Market, by Test Type, Through 2029
Table 5 : Global Cholesterol Screening Market in Routine Health Screening, by Region, Through 2029
Table 6 : Global Diabetes Screening Market in Routine Health Screening, by Region, Through 2029
Table 7 : Global Blood Pressure Screening Market in Routine Health Screening, by Region, Through 2029
Table 8 : Global Cancer Screening Market in Routine Health Screening, by Region, Through 2029
Table 9 : Chance for Down Syndrome, by Age
Table 10 : Global Prenatal Screening Market in Routine Health Screening, by Region, Through 2029
Table 11 : Global Vision and Hearing Screening Market in Routine Health Screening, by Region, Through 2029
Table 12 : Global Bone Density Test Market in Routine Health Screening, by Region, Through 2029
Table 13 : Global Thyroid Profile Test Market in Routine Health Screening, by Region, Through 2029
Table 14 : Global Essential Nutrients Test Market in Routine Health Screening, by Region, Through 2029
Table 15 : Global Other Screening Tests Market in Routine Health Screening, by Region, Through 2029
Table 16 : Global Routine Health Screening Market, by Sample, Through 2029
Table 17 : Global Routine Health Screening Market Based on Blood Sample, by Region, Through 2029
Table 18 : Global Routine Health Screening Market Based on Urine Sample, by Region, Through 2029
Table 19 : Global Routine Health Screening Market Based on Imaging Sample, by Region, Through 2029
Table 20 : Global Routine Health Screening Market based on Other Types of Sample, by Region, Through 2029
Table 21 : Global Routine Health Screening Market, by Technology, Through 2029
Table 22 : Global Routine Health Screening Market based on Quantitative Polymerase Chain Reaction (QPCR) Technology, by Region, Through 2029
Table 23 : Global Routine Health Screening Market based on Q-FISH (Quantitative Fluorescence in Situ Hybridization) Technology, by Region, Through 2029
Table 24 : Global Routine Health Screening Market Based on Immunoassays Technology, by Region, Through 2029
Table 25 : Global Routine Health Screening Market based on Medical Imaging Technology, by Region, Through 2029
Table 26 : Global Routine Health Screening Market based on STELA (Single Telomere Length Analysis), Technology, by Region, Through 2029
Table 27 : Global Routine Health Screening Market based on Other Technologies, by Region, Through 2029
Table 28 : Global Routine Health Screening Market, by Region, Through 2029
Table 29 : North American Routine Health Screening Market, by Country, Through 2029
Table 30 : APAC Routine Health Screening Market, by Country, Through 2029
Table 31 : European Routine Health Screening Market, by Country, Through 2029
Table 32 : ESG Highlights by Major Players, 2023
Table 33 : ESG Rankings for Major Routine Health Screening Companies, 2023
Table 34 : Mergers and Acquisitions: Routine Health Screening Tests Manufacturers and Service Providers, 2021–2024
Table 35 : Major Strategic Alliances in the Routine Health Screening Industry, 2021–2024
Table 36 : Information Sources in this Report
Table 37 : Major Abbreviations Used in This Report
Table 38 : ARUP Laboratories: Company Snapshot
Table 39 : ARUP Laboratories: Product Portfolio
Table 40 : ARUP Laboratories: News/Key Developments, 2021-2024
Table 41 : Cerba Healthcare: Company Snapshot
Table 42 : Cerba Healthcare: Product Portfolio
Table 43 : Cereba Healthcare: News/Key Developments, 2021-2023
Table 44 : Eurofins Scientific: Company Snapshot
Table 45 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 46 : Eurofins Scientific: Product Portfolio
Table 47 : Eurofins Scientific: News/Key Developments, 2022
Table 48 : Exact Science Corp.: Company Snapshot
Table 49 : Exact Science Corp.: Financial Performance, FY 2022 and 2023
Table 50 : Exact Science Corp.: Product Portfolio
Table 51 : Exact Science Corp.: News/Key Developments, 2021–2024
Table 52 : OPKO Health Inc.: Company Snapshot
Table 53 : OPKO Health Inc.: Financial Performance, FY 2022 and 2023
Table 54 : OPKO Health Inc.: Product Portfolio
Table 55 : OPKO Health Inc.: News/Key Developments, 2021-2023
Table 56 : Laboratory Corporation of America Holdings: Company Snapshot
Table 57 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 58 : Laboratory Corporation of America Holdings: Product Portfolio
Table 59 : Laboratory Corporation of America Holdings: News/Key Developments, 2022-2024
Table 60 : Natera Inc.: Company Snapshot
Table 61 : Natera Inc: Financial Performance, FY 2022 and 2023
Table 62 : Natera Inc.: Product Portfolio
Table 63 : Natera Inc.: News/Key Developments, 2024
Table 64 : Quest Diagnostic Inc.: Company Snapshot
Table 65 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 66 : Quest Diagnostic Inc.: Product Portfolio
Table 67 : Quest Diagnostic Inc.: News/Key Developments, 2021-2024
Table 68 : Sonic Healthcare Ltd.: Company Snapshot
Table 69 : Sonic Healthcare Ltd.: Financial Performance FY 2022 and 2023
Table 70 : Sonic Healthcare Ltd.: Product Portfolio
Table 71 : Sonic Healthcare Ltd.: News/Key Developments, 2022
Table 72 : SYNLAB AG: Company Snapshot
Table 73 : SYNLAB AG: Company Financials, FY 2022 and 2023
Table 74 : SYNLAB AG: Product Portfolio
Table 75 : SYNLAB AG: News/Key Developments, 2022
Summary Table : Global Routine Health Screening Market, by Test Type, Through 2029
Table 1 : Projected Number of Adults 50 Years and Older with More than One Chronic Condition in the United States, 2020-2050
Table 2 : Estimated False Positive Probability of One Screening Occasion
Table 3 : Preventive Health Screenings, by Age
Table 4 : Global Routine Health Screening Market, by Test Type, Through 2029
Table 5 : Global Cholesterol Screening Market in Routine Health Screening, by Region, Through 2029
Table 6 : Global Diabetes Screening Market in Routine Health Screening, by Region, Through 2029
Table 7 : Global Blood Pressure Screening Market in Routine Health Screening, by Region, Through 2029
Table 8 : Global Cancer Screening Market in Routine Health Screening, by Region, Through 2029
Table 9 : Chance for Down Syndrome, by Age
Table 10 : Global Prenatal Screening Market in Routine Health Screening, by Region, Through 2029
Table 11 : Global Vision and Hearing Screening Market in Routine Health Screening, by Region, Through 2029
Table 12 : Global Bone Density Test Market in Routine Health Screening, by Region, Through 2029
Table 13 : Global Thyroid Profile Test Market in Routine Health Screening, by Region, Through 2029
Table 14 : Global Essential Nutrients Test Market in Routine Health Screening, by Region, Through 2029
Table 15 : Global Other Screening Tests Market in Routine Health Screening, by Region, Through 2029
Table 16 : Global Routine Health Screening Market, by Sample, Through 2029
Table 17 : Global Routine Health Screening Market Based on Blood Sample, by Region, Through 2029
Table 18 : Global Routine Health Screening Market Based on Urine Sample, by Region, Through 2029
Table 19 : Global Routine Health Screening Market Based on Imaging Sample, by Region, Through 2029
Table 20 : Global Routine Health Screening Market based on Other Types of Sample, by Region, Through 2029
Table 21 : Global Routine Health Screening Market, by Technology, Through 2029
Table 22 : Global Routine Health Screening Market based on Quantitative Polymerase Chain Reaction (QPCR) Technology, by Region, Through 2029
Table 23 : Global Routine Health Screening Market based on Q-FISH (Quantitative Fluorescence in Situ Hybridization) Technology, by Region, Through 2029
Table 24 : Global Routine Health Screening Market Based on Immunoassays Technology, by Region, Through 2029
Table 25 : Global Routine Health Screening Market based on Medical Imaging Technology, by Region, Through 2029
Table 26 : Global Routine Health Screening Market based on STELA (Single Telomere Length Analysis), Technology, by Region, Through 2029
Table 27 : Global Routine Health Screening Market based on Other Technologies, by Region, Through 2029
Table 28 : Global Routine Health Screening Market, by Region, Through 2029
Table 29 : North American Routine Health Screening Market, by Country, Through 2029
Table 30 : APAC Routine Health Screening Market, by Country, Through 2029
Table 31 : European Routine Health Screening Market, by Country, Through 2029
Table 32 : ESG Highlights by Major Players, 2023
Table 33 : ESG Rankings for Major Routine Health Screening Companies, 2023
Table 34 : Mergers and Acquisitions: Routine Health Screening Tests Manufacturers and Service Providers, 2021–2024
Table 35 : Major Strategic Alliances in the Routine Health Screening Industry, 2021–2024
Table 36 : Information Sources in this Report
Table 37 : Major Abbreviations Used in This Report
Table 38 : ARUP Laboratories: Company Snapshot
Table 39 : ARUP Laboratories: Product Portfolio
Table 40 : ARUP Laboratories: News/Key Developments, 2021-2024
Table 41 : Cerba Healthcare: Company Snapshot
Table 42 : Cerba Healthcare: Product Portfolio
Table 43 : Cereba Healthcare: News/Key Developments, 2021-2023
Table 44 : Eurofins Scientific: Company Snapshot
Table 45 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 46 : Eurofins Scientific: Product Portfolio
Table 47 : Eurofins Scientific: News/Key Developments, 2022
Table 48 : Exact Science Corp.: Company Snapshot
Table 49 : Exact Science Corp.: Financial Performance, FY 2022 and 2023
Table 50 : Exact Science Corp.: Product Portfolio
Table 51 : Exact Science Corp.: News/Key Developments, 2021–2024
Table 52 : OPKO Health Inc.: Company Snapshot
Table 53 : OPKO Health Inc.: Financial Performance, FY 2022 and 2023
Table 54 : OPKO Health Inc.: Product Portfolio
Table 55 : OPKO Health Inc.: News/Key Developments, 2021-2023
Table 56 : Laboratory Corporation of America Holdings: Company Snapshot
Table 57 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 58 : Laboratory Corporation of America Holdings: Product Portfolio
Table 59 : Laboratory Corporation of America Holdings: News/Key Developments, 2022-2024
Table 60 : Natera Inc.: Company Snapshot
Table 61 : Natera Inc: Financial Performance, FY 2022 and 2023
Table 62 : Natera Inc.: Product Portfolio
Table 63 : Natera Inc.: News/Key Developments, 2024
Table 64 : Quest Diagnostic Inc.: Company Snapshot
Table 65 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 66 : Quest Diagnostic Inc.: Product Portfolio
Table 67 : Quest Diagnostic Inc.: News/Key Developments, 2021-2024
Table 68 : Sonic Healthcare Ltd.: Company Snapshot
Table 69 : Sonic Healthcare Ltd.: Financial Performance FY 2022 and 2023
Table 70 : Sonic Healthcare Ltd.: Product Portfolio
Table 71 : Sonic Healthcare Ltd.: News/Key Developments, 2022
Table 72 : SYNLAB AG: Company Snapshot
Table 73 : SYNLAB AG: Company Financials, FY 2022 and 2023
Table 74 : SYNLAB AG: Product Portfolio
Table 75 : SYNLAB AG: News/Key Developments, 2022
LIST OF FIGURES
Summary Figure : Global Routine Health Screening Market, by Test Type, 2021-2029
Figure 1 : Differentiating Cancer Screening from Early Diagnosis Based on Symptom Onset
Figure 2 : Role of AI-Based Approaches in Various Themes of Healthcare Research
Figure 3 : Detection and Intervention through Cancer Screening
Figure 4 : Global Routine Health Screening Market Dynamics
Figure 5 : 10 Common Chronic Conditions in Adults 65+, U.S., 2024
Figure 6 : Percentage of Visits to Health Centers by Primary Reason for the Visit: United States, 2020
Figure 7 : Per Capita Healthcare Expenditure for Few Top Countries, 2021
Figure 8 : Global Routine Health Screening Market Shares, by Test Type, 2023
Figure 9 : Global Cholesterol Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 10 : Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 11 : Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 12 : Global Cancer Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 13 : Global Prenatal Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 14 : Global Vision and Hearing Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 15 : Global Bone Density Test Market in Routine Health Screening, by Region, 2021-2029
Figure 16 : Global Thyroid Profile Test Market in Routine Health Screening, by Region, 2021-2029
Figure 17 : Global Essential Nutrients Test Market in Routine Health Screening, by Region, 2021-2029
Figure 18 : Global Other Screening Tests Market in Routine Health Screening, by Region, 202-2029
Figure 19 : Global Routine Health Screening Market, by Sample, 2021-2029
Figure 20 : Global Routine Health Screening Market Shares, by Sample, 2023
Figure 21 : Diagnostic Significance of Urinary Markers and Metabolites for Disease
Figure 22 : Global Routine Health Screening Market, by Technology, 2021-2029
Figure 23 : Global Routine Health Screening Market, by Region, 2021-2029
Figure 24 : Global Routine Health Screening Market Shares, by Region, 2023
Figure 25 : North American Routine Health Screening Market Shares, by Country, 2023
Figure 26 : APAC Routine Health Screening Market Shares, by Country, 2023
Figure 27 : European Routine Health Screening Market Shares, by Country, 2023
Figure 28 : Global Routine Health Screening Market Shares, by Key Manufacturers and Service Providers, 2023
Figure 29 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 30 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 31 : Exact Science Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 32 : Exact Science Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 33 : OPKO Health Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34 : OPKO Health Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 36 : Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2022
Figure 37 : Natera Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 38 : Natera Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Quest Diagnostic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Sonic Healthcare Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 41 : Sonic Healthcare Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 42 : SYNLAB AG: Revenue Shares, by Business Unit, FY 2023
Figure 43 : SYNLAB AG.: Revenue Shares, by Country/Region, FY 2023
Summary Figure : Global Routine Health Screening Market, by Test Type, 2021-2029
Figure 1 : Differentiating Cancer Screening from Early Diagnosis Based on Symptom Onset
Figure 2 : Role of AI-Based Approaches in Various Themes of Healthcare Research
Figure 3 : Detection and Intervention through Cancer Screening
Figure 4 : Global Routine Health Screening Market Dynamics
Figure 5 : 10 Common Chronic Conditions in Adults 65+, U.S., 2024
Figure 6 : Percentage of Visits to Health Centers by Primary Reason for the Visit: United States, 2020
Figure 7 : Per Capita Healthcare Expenditure for Few Top Countries, 2021
Figure 8 : Global Routine Health Screening Market Shares, by Test Type, 2023
Figure 9 : Global Cholesterol Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 10 : Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 11 : Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 12 : Global Cancer Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 13 : Global Prenatal Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 14 : Global Vision and Hearing Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 15 : Global Bone Density Test Market in Routine Health Screening, by Region, 2021-2029
Figure 16 : Global Thyroid Profile Test Market in Routine Health Screening, by Region, 2021-2029
Figure 17 : Global Essential Nutrients Test Market in Routine Health Screening, by Region, 2021-2029
Figure 18 : Global Other Screening Tests Market in Routine Health Screening, by Region, 202-2029
Figure 19 : Global Routine Health Screening Market, by Sample, 2021-2029
Figure 20 : Global Routine Health Screening Market Shares, by Sample, 2023
Figure 21 : Diagnostic Significance of Urinary Markers and Metabolites for Disease
Figure 22 : Global Routine Health Screening Market, by Technology, 2021-2029
Figure 23 : Global Routine Health Screening Market, by Region, 2021-2029
Figure 24 : Global Routine Health Screening Market Shares, by Region, 2023
Figure 25 : North American Routine Health Screening Market Shares, by Country, 2023
Figure 26 : APAC Routine Health Screening Market Shares, by Country, 2023
Figure 27 : European Routine Health Screening Market Shares, by Country, 2023
Figure 28 : Global Routine Health Screening Market Shares, by Key Manufacturers and Service Providers, 2023
Figure 29 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 30 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 31 : Exact Science Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 32 : Exact Science Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 33 : OPKO Health Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34 : OPKO Health Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 36 : Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2022
Figure 37 : Natera Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 38 : Natera Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Quest Diagnostic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Sonic Healthcare Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 41 : Sonic Healthcare Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 42 : SYNLAB AG: Revenue Shares, by Business Unit, FY 2023
Figure 43 : SYNLAB AG.: Revenue Shares, by Country/Region, FY 2023
